95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.97%
Revenue growth above 1.5x FNV's 2.23%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
10.64%
Gross profit growth above 1.5x FNV's 6.01%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
13.90%
EBIT growth 50-75% of FNV's 19.38%. Martin Whitman would suspect suboptimal resource allocation.
13.42%
Operating income growth above 1.5x FNV's 8.68%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
15.07%
Net income growth at 75-90% of FNV's 20.08%. Bill Ackman would press for improvements to catch or surpass competitor performance.
14.29%
EPS growth at 75-90% of FNV's 17.43%. Bill Ackman would push for improved profitability or share repurchases to catch up.
14.29%
Diluted EPS growth at 75-90% of FNV's 17.43%. Bill Ackman would expect further improvements in net income or share count reduction.
0.04%
Share count expansion well above FNV's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.05%
Diluted share count expanding well above FNV's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
15.01%
OCF growth under 50% of FNV's 48.94%. Michael Burry might suspect questionable revenue recognition or rising costs.
-74.72%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
172.48%
Similar 10Y revenue/share CAGR to FNV's 177.64%. Walter Schloss might see both firms benefiting from the same long-term demand.
100.60%
5Y revenue/share CAGR 1.25-1.5x FNV's 85.48%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
65.26%
3Y revenue/share CAGR above 1.5x FNV's 6.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
238.06%
10Y OCF/share CAGR under 50% of FNV's 479.32%. Michael Burry would worry about a persistent underperformance in cash creation.
170.21%
5Y OCF/share CAGR is similar to FNV's 181.36%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
100.04%
3Y OCF/share CAGR above 1.5x FNV's 65.71%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
384.37%
Below 50% of FNV's 840.89%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
173.02%
5Y net income/share CAGR 1.25-1.5x FNV's 156.89%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
95.04%
3Y net income/share CAGR above 1.5x FNV's 27.75%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
53.97%
10Y equity/share CAGR at 75-90% of FNV's 60.76%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
40.97%
5Y equity/share CAGR 1.25-1.5x FNV's 27.88%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
19.77%
3Y equity/share CAGR above 1.5x FNV's 5.06%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
282.43%
10Y dividend/share CAGR above 1.5x FNV's 132.67%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
76.17%
5Y dividend/share CAGR 1.25-1.5x FNV's 65.33%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
25.66%
3Y dividend/share CAGR at 75-90% of FNV's 29.41%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
147.04%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
3.14%
Asset growth at 50-75% of FNV's 5.52%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.43%
50-75% of FNV's 4.86%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
1.99%
Debt growth of 1.99% while FNV is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-17.67%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.